Screening for vitamin D deficiency: Defining vitamin D deficiency, target thresholds of treatment and estimating the benefits of treatment

Pathology

Volumn 44, Issue 2, 2012, Pages 160-165

  Glendenning, Paul ^a,b,c   Inderjeeth, Charles A ^b,d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Cost benefit analyses; Target of therapy; Vitamin D

Indexed keywords

EID: 84858318392     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834e8df6     Document Type: Article

References (64)

1. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9: 709-15.
2. Wharton B, Bishop N. Rickets. Lancet 2003; 362: 1389-400. (Pubitemid 37338342)
3. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501. (Pubitemid 32762324)
4. Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 2007; 22: 1668-71. (Pubitemid 351235133)
5. Slomski A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011; 305: 453-4; 56.
6. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: National Academies Press, 2011
7. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
8. Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151-4.
9. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-6. (Pubitemid 36417827)
10. Hansen KE, Jones AN, Lindstrom MJ, et al. Vitamin D insufficiency: disease or no disease? J Bone Miner Res 2008; 23: 1052-60. (Pubitemid 351915727)
11. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805-6. (Pubitemid 28112350)
12. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-21. (Pubitemid 32323007)
13. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294: 2336-41. (Pubitemid 41607410)
14. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009; 94: 1244-50.
15. Jesudason D, Need AG, Horowitz M, et al. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002; 31: 626-30. (Pubitemid 35449707)
16. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116: 634-9. (Pubitemid 38490539)
17. Ensrud KE, Taylor BC, Paudel ML, et al. Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 2009; 94: 2773-80.
18. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 149: 242-50.
19. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370: 657-66. (Pubitemid 47285316)
20. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692.
21. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonver-tebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551-61.
22. Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf) 2010; 73: 277-85.
23. Grethen E, McClintock R, Gupta CE, et al. Vitamin D and hyperparathyr-oidism in obesity. J Clin Endocrinol Metab 2011; 96: 1320-6.
24. Nuti R, Martini G, Valenti R, et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 2001; 250: 361-6. (Pubitemid 32955621)
25. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83. (Pubitemid 28135983)
26. Boudville N, Inderjeeth C, Elder GJ, Glendenning P. Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure. Clin Endocrinol (Oxf) 2010; 73: 299-304.
27. Noble JM, McGuiness M, Glendenning P. Low rate of compliance with ergocalciferol therapy in vitamin-D-deficient patients with hip fracture. Med J Aust 2002; 177: 280.
28. Seymour HM, Glendenning P. Fit for a fracture. Med J Aust 2005; 183: 213-4. (Pubitemid 41150334)
29. Glendenning P. Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines. Intern Med J 2003; 33: 598-603. (Pubitemid 38121807)
30. Manson JE, Mayne ST, Clinton SK. Vitamin D and prevention of cancer ready for prime time? N Engl J Med 2011; 364: 1385-7.
31. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-91. (Pubitemid 46890428)
32. Glendenning P. Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin D. Am J Clin Nutr 2003; 77: 522-3. (Pubitemid 36133400)
33. Lips P, Chapuy MC, Dawson-Hughes B, et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999; 9: 394-7. (Pubitemid 29231730)
34. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 2004; 50: 2195-7. (Pubitemid 39425873)
35. Glendenning P, Noble JM, Taranto M, et al. Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases. Ann Clin Biochem 2003; 40: 546-51. (Pubitemid 37152208)
36. Glendenning P, Taranto M, Noble JM, et al. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 2006; 43: 23-30. (Pubitemid 43105054)
37. Cavalier E, Wallace AM, Carlisi A, et al. Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clin Chem Lab Med 2011; 49: 555-8.
38. Glendenning P, Chew GT, Seymour HM, et al. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009; 45: 870-5.
39. Connell AB, Jenkins N, Black M, et al. Overreporting of vitamin D deficiency with the Roche Elecsys Vitamin D3 (25-OH) method. Pathology 2011; 43: 368-71.
40. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011; 12: 19-28.
41. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009; 46: 79-81.
42. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008; 88: 511S-2S.
43. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006; 91: 3055-61. (Pubitemid 44271755)
44. Stepman HC, Vanderroost A, Stockl D, Thienpont LM. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D in serum of infants and adults. Clin Chem Lab Med 2011; 49: 253-6.
45. Shah I, James R, Barker J, et al. Misleading measures in Vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr J 2011; 10: 46.
46. Willis MS. The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden. Int J Technol Assess Health Care 2002; 18: 791-807. (Pubitemid 36125885)
47. Grant WB, Schwalfenberg GK, Genuis SJ, Whiting SJ. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010; 54: 1172-81.
48. Grant WB, Cross HS, Garland CF, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009; 99: 104-13.
49. Health Canada. Economic Burden of Illness in Canada, 1998. Ottawa: Health Canada, 2002. http://www.phac-aspc.gc.ca/publicat/ebic-femc98/pdf/ebic1998.pdf
50. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarctionin men: a prospective study. Arch Intern Med 2008; 168: 1174-80. (Pubitemid 351831400)
51. Pilz S, Dobnig H, Fischer JE, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 2611-3.
52. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-11.
53. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-6. (Pubitemid 44115368)
54. Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008; 19: 666-71.
55. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006. (Pubitemid 38544282)
56. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007; 135: 1095-6; author reply 97-8.
57. Grant WB. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermatoendocrinol 2009; 1: 37-42.
58. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations invitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7: 28
59. Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 2000; 11: 669-74.
60. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-42.
61. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-2. (Pubitemid 24124866)
62. Peiris AN, Bailey BA, Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Mil Med 2008; 173: 1214-8.
63. Duque G, Close JJ, de Jager JP, et al. Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention. Med J Aust 2010; 193: 173-9.
64. Ebeling PR. Routine screening for vitamin D deficiency in early pregnancy: past its due date? Med J Aust 2011; 194: 332-3